779 related articles for article (PubMed ID: 22391123)
1. Epigenetic biomarkers in prostate cancer: Current and future uses.
Chiam K; Ricciardelli C; Bianco-Miotto T
Cancer Lett; 2014 Jan; 342(2):248-56. PubMed ID: 22391123
[TBL] [Abstract][Full Text] [Related]
2. Epigenetics in human gliomas.
Kreth S; Thon N; Kreth FW
Cancer Lett; 2014 Jan; 342(2):185-92. PubMed ID: 22531315
[TBL] [Abstract][Full Text] [Related]
3. Road to early detection of pancreatic cancer: Attempts to utilize epigenetic biomarkers.
Fukushige S; Horii A
Cancer Lett; 2014 Jan; 342(2):231-7. PubMed ID: 22450751
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic changes in prostate cancer: implication for diagnosis and treatment.
Li LC; Carroll PR; Dahiya R
J Natl Cancer Inst; 2005 Jan; 97(2):103-15. PubMed ID: 15657340
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic inactivation of DNA repair in breast cancer.
Nowsheen S; Aziz K; Tran PT; Gorgoulis VG; Yang ES; Georgakilas AG
Cancer Lett; 2014 Jan; 342(2):213-22. PubMed ID: 22634493
[TBL] [Abstract][Full Text] [Related]
6. Epigenetics in prostate cancer: biologic and clinical relevance.
Jerónimo C; Bastian PJ; Bjartell A; Carbone GM; Catto JW; Clark SJ; Henrique R; Nelson WG; Shariat SF
Eur Urol; 2011 Oct; 60(4):753-66. PubMed ID: 21719191
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic biomarkers in lung cancer.
Liloglou T; Bediaga NG; Brown BR; Field JK; Davies MP
Cancer Lett; 2014 Jan; 342(2):200-12. PubMed ID: 22546286
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic modifications in prostate cancer.
Ngollo M; Dagdemir A; Karsli-Ceppioglu S; Judes G; Pajon A; Penault-Llorca F; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon DJ
Epigenomics; 2014; 6(4):415-26. PubMed ID: 25333850
[TBL] [Abstract][Full Text] [Related]
9. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
Dobosy JR; Roberts JL; Fu VX; Jarrard DF
J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic biomarkers of colorectal cancer: Focus on DNA methylation.
Coppedè F
Cancer Lett; 2014 Jan; 342(2):238-47. PubMed ID: 22202641
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic biomarkers in laboratory diagnostics: emerging approaches and opportunities.
Sandoval J; Peiró-Chova L; Pallardó FV; García-Giménez JL
Expert Rev Mol Diagn; 2013 Jun; 13(5):457-71. PubMed ID: 23782253
[TBL] [Abstract][Full Text] [Related]
12. Global levels of specific histone modifications and an epigenetic gene signature predict prostate cancer progression and development.
Bianco-Miotto T; Chiam K; Buchanan G; Jindal S; Day TK; Thomas M; Pickering MA; O'Loughlin MA; Ryan NK; Raymond WA; Horvath LG; Kench JG; Stricker PD; Marshall VR; Sutherland RL; Henshall SM; Gerald WL; Scher HI; Risbridger GP; Clements JA; Butler LM; Tilley WD; Horsfall DJ; Ricciardelli C;
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2611-22. PubMed ID: 20841388
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic deregulation across chromosome 2q14.2 differentiates normal from prostate cancer and provides a regional panel of novel DNA methylation cancer biomarkers.
Devaney J; Stirzaker C; Qu W; Song JZ; Statham AL; Patterson KI; Horvath LG; Tabor B; Coolen MW; Hulf T; Kench JG; Henshall SM; Pe Benito R; Haynes AM; Mayor R; Peinado MA; Sutherland RL; Clark SJ
Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):148-59. PubMed ID: 21098650
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs in prostate cancer: from biomarkers to molecularly-based therapeutics.
Gordanpour A; Nam RK; Sugar L; Seth A
Prostate Cancer Prostatic Dis; 2012 Dec; 15(4):314-9. PubMed ID: 22333688
[TBL] [Abstract][Full Text] [Related]
15. The epigenetic potentials of dietary polyphenols in prostate cancer management.
Abbas A; Patterson W; Georgel PT
Biochem Cell Biol; 2013 Dec; 91(6):361-8. PubMed ID: 24219277
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic targets in the diagnosis and treatment of prostate cancer.
Manoharan M; Ramachandran K; Soloway MS; Singal R
Int Braz J Urol; 2007; 33(1):11-8. PubMed ID: 17335593
[TBL] [Abstract][Full Text] [Related]
17. Cancer epigenetics.
Taby R; Issa JP
CA Cancer J Clin; 2010; 60(6):376-92. PubMed ID: 20959400
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic alterations as cancer diagnostic, prognostic, and predictive biomarkers.
Deng D; Liu Z; Du Y
Adv Genet; 2010; 71():125-76. PubMed ID: 20933128
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation and histone modifications as epigenetic regulation in prostate cancer (Review).
Nowacka-Zawisza M; Wiśnik E
Oncol Rep; 2017 Nov; 38(5):2587-2596. PubMed ID: 29048620
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic biomarkers for human cancer: the time is now.
Mulero-Navarro S; Esteller M
Crit Rev Oncol Hematol; 2008 Oct; 68(1):1-11. PubMed ID: 18430583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
